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Coronary artery ectasia (CAE) is defined as localized or diffuse dilatation of coronary artery
lumen exceeding the largest diameter of an adjacent normal vessel more than 1.5 fold. The
incidence of CAE is reported as 0.3–4.9% of patients undergoing coronary angiography. The
rate of recognition may increase with the use of new non-invasive imaging methods like
computed tomography (CT) and magnetic resonance (MR) coronary angiography. Athero-
sclerosis is considered as the main etiologic factor responsible for more than 50% of cases
in adults while Kawasaki disease is the most common cause in children or young adults.
Coronary ectasia is thought to be a result of exaggerated expansive remodeling, which is
eventuated as a result of enzymatic degradation of the extracellular matrix and thinning of
the vessel media. Patients with CAE without significant coronary narrowing may present
with angina pectoris, positive stress tests or acute coronary syndromes. Ectatic vessel may
be an origin of thrombus formation with distal embolization, vasospasm or vessel rupture.
The prognosis of CAE depends directly on the severity of the concomitant coronary artery
disease. Antiplatelet drugs underlie the therapy. Other management strategies in CAE
involve both the prevention of thromboembolic complications and percutaneous or surgical
revascularization.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Table 1 – Markis classification of coronary artery ectasia.
Types of CAE Definition
Type 1 Diffuse ectasia of two or three vessels
Type 2 Diffuse ectasia in one vessel and localized
disease in another
Type 3 Diffuse ectasia in one vessel only
Type 4 Localized or segmental involvement
Table 2 – Etiology of coronary artery ectasia.
 Atherosclerosis
 Coronary artery revascularisation procedures (balloon angioplasty,
stent implantation, laser angioplasty, atherectomy, brachytherapy)
 Vasculitides (Kawasaki disease, polyarteritis nodosa, syphilis,
Takayasu disease, Wegener granulomatosis, Giant cell arteritis,
Churg Strauss Syndrome)
 Congenital malformations
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Coronary artery ectasia (CAE) is a well-recognized but rela-
tively uncommon finding encountered during diagnostic
coronary angiography [1–3]. It is commonly defined as inap-
propriate dilation of the coronary arteries exceeding the
largest diameter of an adjacent normal vessel more than 1.5
fold [1,4] (Fig. 1). The term ‘ectasia’ refers to diffuse dilation of
a coronary artery whilst focal dilation is called as ‘coronary
aneurysm’ [5]. Even though several mechanisms are sug-
gested the pathophysiology of CAE is still underrecognized.
Similarly no consensus exists about the natural history and
management of this condition because of the relative scarcity
of data. CAE represents not only an anatomical variant but
also a clinical constellation of coronary artery disease (CAD)
like association with myocardial ischemia and acute coron-
ary syndromes. The purpose of this review is to update and
summarize the clinical features of CAE.
 Chest traumas
 Connective tissue disorders (rheumatoid arthritis, Systemic lupus
erythematosus, scleroderma, ankylosing spondylitis, Behc-et’s
disease, Psoriasis)
 Collagenopathies (Marfan’s syndrome, Ehlers-Danlos syndrome,
hereditary hemorrhagic telangiectasia)
 Primary hyperaldosteronism2. Epidemiology and classification
Incidence of CAE detected by means of coronary arteriogram
has been found to vary between 0.3% and 4.9% [1,3]. In the
largest series from the CASS registry, Swaye et al. found CAE
in 4.9% of coronary angiograms and the incidence is higher
in men than in women (2.2% vs. 0.5% respectively) [3] and
postmortem incidence is given 1.4%. Advent of new non-
invasive technologies such as computed tomography (CT) and
magnetic resonance (MR) coronary angiography, may increase
the rate of recognition [6]. Zeina et al. found the prevalence of
CAE 8% by coronary CT angiography [7]. Markis suggested a
classification of CAE according to the number and diffuseness
of involved coronary vessels (Table 1) [7,8]. According to the
diameter of the vessel lumen CAE is classified as small
(o5mm), medium (5–8mm) or giant (48mm).Fig. 1 – Ectasia of right coronary artery (arrow) in a 78 yo
female patient.3. Etiology and pathophysiology
Atherosclerosis is considered as the main etiologic factor
responsible for more than 50% of cases in adults [1,3,4,7,9]
while Kawasaki disease is the most common cause in
children or young adults [6–8]. Etiology of CAE is demon-
strated in Table 2 [10,11]. There are marked histopathological
similarities between ectasia and atherosclerosis. Arterial
lumen may be narrowed, preserved or dilated with progres-
sion of atherosclerosis. The exact mechanism of luminal
dilation in some atherosclerotic vessels is unclear while
atherosclerosis predominantly causes narrowing of the vessel
lumen. Certain plaques, as a result of a phenomenon so
called ‘arterial remodeling’, do not reduce luminal size,
presumably because of expansion of the media and external
elastic membrane [12]. This finding also may be operative in
the case of ectasia or aneurysm of other vessels. Observa-
tions with the use of intravascular ultrasound demonstrated
that arterial remodeling may be bidirectional according to the
expansion or shrinkage of external elastic membrane (i.e.
positive and negative remodeling respectively) [12]. Positive
(or expansive) remodeling is principally a compensatory
mechanism to preserve luminal size during the progres-
sion of atherosclerosis. CAE is thought to be a result of
exaggerated expansive remodeling in which both external
elastic membrane and luminal size increase [11,13]. Enzy-
matic degradation of the extracellular matrix by matrix-
metalloproteinases and other lytic enzymes and thinning of
the tunica media associated with severe chronic inflamma-
tion is suggested as the key pathogenetic mechanism of
the exaggerated expansive remodeling. The severity of the
changes in the media correlates positively with the diameter
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intact and uninvolved media layer [11]. CAE is associated with
overexpression of matrix metalloproteinases [14]. Signifi-
cantly higher levels of C-reactive protein (CRP) [15] and
vascular endothelial growth factor (VEGF) [16] were found
among patients with CAE, which suggests more severe and
extensive inflammation and neovascularization in ectasia.
Association between the chronic stimulation of endogenous
nitric oxide that leads to vascular relaxation and the occurrence
of areas of ectasia is another suggested mechanism [2]. Accord-
ing to Manginas, CAE occurs due to two different mechanisms in
two distinct patient groups: (i) rarely in subjects without cor-
onary atherosclerosis as a result of interstitial NO vascular
overstimulation and (ii) commonly in patients with concomitant
CAD due to severe and chronic arterial inflammation [10].
Genetic predisposition of coronary ectasia could be sug-
gested from its association with angiotensin-converting
enzyme DD genotype [17] and with hereditary conditions like
familial hypercholesterolemia [18].
There is controversial association between hypertension
and CAE [3,7,8]. According to Zeina et al. CAE is not correlated
with diabetes mellitus, hypertension, hyperlipidemia, smok-
ing and family history of CAD [7]. CAE is also related to apical
hypertrophic cardiomyopathy with high wall tension espe-
cially during ventricular systole [19]. Left ventricular diastolic
dysfunction was demonstrated in CAE by conventional and
tissue Doppler imaging in a small study [20].
Formation of aneurysm may be seen following percutaneous
coronary interventions [9]. These may occur during coronary
balloon angioplasty, but more importantly following coronary
stent placement, atherectomy and brachytherapy [10,21]. Injury
of the media of a blood vessel has still the main responsibility
after percutaneous revascularization procedure for coronary
aneurysm development [9]. Cardiac involvement is the most
important manifestation of Kawasaki disease and includes
coronary artery aneurysms and ectasias, premature athero-
sclerosis, thrombosis, or occlusion with myocardial infarction
[22]. Coronary aneurysms develop in 15–25% of untreated chil-
dren with Kawasaki disease [22,23], but after the introduction of
the aspirin and intravenous gamma globulin therapy, resolution
occurs at least 50% of the cases [23]. Right coronary artery is the
most frequently involved vessel in the coronary tree (40–61%)
(Fig. 1) which is followed by the left anterior descending artery
(15–32%) and left circumflex artery (15–23%) [1,3,6,7]. Isolated left
main trunk ectasia is almost an exception. Ectasia is limited in
one coronary artery in 75% of cases. CAE is mostly associated
with obstructive coronary artery disease and isolated CAE has
remarkably low incidence (o20%). CAE may coexist with aneur-
ysms of other arterial beds, particularly abdominal aorta, even
with venous varicosities. This finding is conversely not sup-
ported by Hartnell et al. [1].Fig. 2 – Ectasia of LAD mid segment and intracoronary
thrombi (arrow) in a 65 yo male patient presented with
acute coronary syndrome.4. Diagnosis
Gold standard in diagnosing coronary ectasia is coronary
angiogram. IVUS is available for evaluation of luminal exten-
sion and vessel wall pathologies and also for identification of
normal arterial segments adjacent to stenotic lesions, which
are often falsely characterized as aneurysms by conventionalangiography [11]. Distortions in flow and washout are com-
mon in CAE, and are clearly associated with the severity of
ectasia. Angiographic signs of turbulent and stagnant flow
include delayed antegrade contrast filling, a segmental back
flow (milking phenomenon) and local deposition of contrast
in the dilated coronary segment (stasis) [5]. Other imaging
methods like magnetic resonance angiography (MRA), multi-
slice CT or the electron beam CT are also applicable for this
vascular pathology [6]. However, CT should not be a choice
as a technique for the follow up of patients because of its
high radiation dose. Instead, MRA, being a non-invasive, non-
radiating technique, may be utilized for follow up of CAE [5].
Transthoracic or transesophageal echocardiography may be
option for the proximally located ectasias.5. Clinical significance and symptoms
Clinical significance of CAE is not fully clarified. There is no
typical symptom that could be associated with coronary ectasia.
The symptoms may be associated with the concomitant CAD,
Kawasaki disease or connective tissue disorder, although most
of the patients are asymptomatic. Patients with CAE without
significant coronary narrowing may still present with angina
pectoris, positive stress tests, or acute coronary syndromes
[24–26]. Decreased coronary flow velocity or stagnancy of cor-
onary blood flow may cause exercise-induced angina regardless
of coexisting stenotic coronary disease [5]. Additionally acute
coronary syndromes may result from atherosclerotic lesions
within ectatic regions of the coronary arteries which appear to
be highly inflamed high-risk plaques with tendency to rupture.
Formation of intracoronary thrombus and dissipation of micro-
emboli to distal coronary tree may also be the subject of acute
coronary syndrome, which is precipitated from sluggish flow
in the ectatic coronary segments [7,27] (Fig. 2). Angiographic
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 2 4 2 – e 2 4 7 e245findings such as topographical extent of CAE and corrected TIMI
frame count are associated with severity of angina in patients
with CAE [25]. Gulec et al. observed that in patients with isolated
CAE, both epicardial flow and microvascular perfusion are
diminished. Coronary microvascular perfusion is impaired even
in the setting of normal epicardial flow [28]. CAE without
significant epicardial stenosis may lead to exercise induced
myocardial ischemia especially if coronary tree is diffusely
involved [24]. Akyurek et al. measured the blood flow velocity
and coronary flow reserve invasively by use of Doppler scanning
flow wire in patients with isolated CAE and in a control group.
They reported significantly higher volumetric coronary blood
flow but reduced coronary flow reserve in patients with diffuse
CAE, suggesting that microcirculatory dysfunction may be the
underlying cause of exercise-induced myocardial ischemia in
CAE [29]. Ectatic coronary arteries tend to develop vasospasms
which may also bring angina or acute coronary syndrome [7,30].
Observation of isolated CAE among patients younger than
age 50 must be suggestive of connective tissue disorders or
vasculitides. In such circumstances further investigations
must be under consideration. Moreover an overlooked diag-
nosis, Kawasaki disease must be realized in young adults
presented with coronary aneurysm. The most important
clinical features suggesting coronary aneurysms are due to
Kawasaki disease are the history of Kawasaki disease com-
patible illness, Asian race, proximal location of coronary
aneurysms, giant (48 mm) aneurysms, young age (o30) and
absence of significant coronary stenosis (Z50%). Accurate
diagnosis of Kawasaki disease is important because the
management strategies differ from conventional athero-
sclerotic ectasias [31].6. Prognosis
The prognosis of CAE depends directly on the severity of the
concomitant coronary artery disease. CAE with obstructive
coronary artery disease is a vicious condition because of
its potential of resulting in several adverse cardiac events.
Although no difference in mortality between patients with or
without CAE was demonstrated, isolated ectasia still bears
risk of myocardial ischemia and infarction [5,24,28,29].
According to the classification defined by Markis, type I and
type II coronary ectasias bring about the worse prognosis
than type III and IV. Mortality rate at 2 years is reported 15%
[8]. No relation between diameter of ectasia and survival is
reported.Fig. 3 – A 56 yo male patient presented with acute anterior
MI. Diffuse ectasia and acute thrombotic occlusion was
seen in LAD and huge diagonal artery.7. Treatment
There is still no consensus for management of CAE. Con-
ducting large scaled randomized trials which compares
different treatment modilities is difficult because of relative
rarity of this condition. In the case of accompanying CAD, the
management is same as for CAD alone. Intense risk factor
modification for primary and secondary prevention must be
considered.
Administration of aspirin to all CAE patients is logical due
to the high coincidence with coronary artery disease andreported cases of myocardial infarction [5]. Statins may have
a role by inhibiting matrix metalloproteinases [32]. Nitrates
by dilating epicardial coronary arteries, may cause the steal
syndrome and exacerbate anginal symptoms so are not
recommended [9,26]. Isolated CAE has a better prognosis
and the antiplatelet drugs underlie the therapy [5]. Manage-
ment of isolated coronary artery ectasia in the cases with
angina or myocardial ischemia includes acetylsalicylic acid,
statin and antiischemic medications (calcium channel blocker,
beta blocker and trimetazidine) as required [26,33,34] in addi-
tion to risk factor modification for atherosclerosis.
Acute coronary syndrome associated with CAE must be
managed on an individual basis. Existence of thrombus may
require to implement additional therapeutic decisions, i.e.
thrombolysis, heparin infusion or glycoprotein IIb/IIIa recep-
tor inhibitors as needed in the case of acute coronary
syndrome [5,35–37] (Fig. 3). Thrombus aspiration during
primary PCI should be considered [35]. Chronic anticoagula-
tion is suggested by many authors however no randomized
trial demonstrated its benefit on CAE. The anticipated benefit
must be counterbalanced with the risk of hemorrhage.
Percutaneous or surgical revasvularization may be option
among patients with coexisting obstructive lesions and sig-
nificant ischemia despite medical therapy [5,38,39]. Coronary
intervention of stenosis adjacent to ectasia has inherent
difficulties with regards to optimal stent sizing, misplace-
ment and embolization of the stent, early stent thrombosis
and restenosis [5,40]. Extra care must be taken during stent-
ing because adequate stent expansion and wall apposition is
needed [10]. The implantation of covered stents offers super-
ior results compared to the bare metal stents, but long term
benefit has not been adequately proven [40]. Coronary aneur-
ysm formation after drug eluting stent implantation is also
notified as a rare complication [41,42]. Parallel stenting with
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coronary artery stenting [43]. The use of large sized periph-
eral stents in ectatic coronary arteries also may be possible
[44]. Indications for surgical treatment are identical to those
in the case of coronary heart disease [9]. Additionally in those
patients with evidence of enlargement of saccular coronary
artery aneurysms with increased risk of rupture surgical
resection may be an alternative [45,46]. As previously men-
tioned the usage of aspirin and intravenous gamma globulin
therapy reduces the occurrence of coronary ectasias in
patients with Kawasaki disease [23].8. Conclusion
CAE is a vascular disease mostly a form of atherosclerosis
seen in 0.3–4.9% of diagnostic coronary angiography
procedures. A pattern of vascular remodeling, exaggerated
expansive remodeling with enzymatic degradation of the
extracellular matrix and thinning of the vessel media as a
result of chronic inflammation is thought to be a major
pathophysiologic process. The symptoms may be associated
with the concomitant CAD, Kawasaki disease or connective
tissue disorder although most of the patients are asympto-
matic. Clinical importance especially leans on its association
with acute coronary events. Treatment options include, risk
factor modifications for CAD, antiischemic therapy, antith-
rombotic management and percutaneous or surgical revas-
cularization techniques. Future trials are warranted in order
to optimize the management of CAE.
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